Tafazzoli, Ali
Reifsnider, Odette S.
Bellanca, Leana
Ishak, Jack
Carrasco, Marc
Rakonczai, Pal
Stargardter, Matthew
Linden, Stephan
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 5 May 2022
Accepted: 14 November 2022
First Online: 4 December 2022
Declarations
:
: Stephan Linden, Leana Bellanca and Marc Carrasco are employees of Boehringer Ingelheim. Odette S. Reifsnider, Jack Ishak, Pal Rakonczai and Matthew Stargardter are employees of Evidera, a healthcare research firm that provides consulting and other research services to the biopharmaceutical and medical device industry, while Ali Tafazzoli was employed by Evidera during the conduct of this study and creation of this article. In these salaried positions, they work with a variety of companies and are explicitly precluded from accepting any payment or honoraria directly from those companies for services rendered. Evidera received payment from Boehringer Ingelheim for collaboration on this project and article.